About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

BOTOX® Open-Label Treatment in Pediatric Upper Limb Spasticity

NCT01603615·48 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Allergan

Age

2–17

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Minimum weight of 10 Kilograms (kg) / 22 Pounds (lb)
Upper limb spasticity due to cerebral palsy or stroke

You may not be if

Muscular dystrophy, myasthenia gravis, Eaton-Lambert syndrome, amyotrophic lateral sclerosis, or mitochondrial disease
Uncontrolled epilepsy
Botulinum Toxin therapy of any serotype for any condition within the last 3 months
History of surgical intervention of the upper limb within 1 year, or planned surgery of any limb during the study

The record

StatusCompleted

PhasePhase 3

Taking part220

StartedOct 2012

UpdatedAug 21, 2019

Conditions

Pediatrics Muscle Spasticity Cerebral Palsy Stroke

Where48

ABS Health, LLC
Pasadena, California, United States
Harrison Clinical Management
Pomona, California, United States
Rady Children's Hospital San Diego
San Diego, California, United States